FMT in Transplant-related Gastrointestinal Mucositis

FMT in Transplant-related Gastrointestinal Mucositis Treatment

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07622849

Enrollment

Registered

2026-06-03

Start date

2023-03-01

Completion date

2028-12-01

Last updated

2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transplant-related Gastrointestinal Mucositis

Brief summary

With the stem cell transplant increasing, patients which effected with transplant-related gastrointestinal mucositis (TRGM) have also increased. To evaluate the safety and efficacy of FMT for TRGM, patients with TRGM were recruited.

Interventions

BIOLOGICALFecal Microbiota

fecal microbiota transplantation

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

15 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Transplant-related gastrointestinal mucositis

Exclusion criteria

* age\>65; or age\<15;

Design outcomes

Primary

Measure	Time frame	Description
aGVHD	2 weeks, 4 weeks, 2 months, 3 months	Occurrence time and severity of aGVHD

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026